Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

COVID vaccines slash viral spread – but Delta is an unknown

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 596, 17-18 (2021)

doi: https://doi.org/10.1038/d41586-021-02054-z

Updates & Corrections

  • Correction 13 August 2021: An earlier version of this story said the studies had seen a drop of 78% and 41%, in reduction of infectiousness. In fact the studies reported a drop of 78%, and 41% in infectiousness. The text has been updated to reflect this.

References

  1. Layan, M. et al. Preprint at https://doi.org/10.1101/2021.07.12.21260377 (2021).

  2. Prunas, O. et al. Preprint at https://doi.org/10.1101/2021.07.13.21260393 (2021).

  3. Harris, R. J. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMc2107717 (2021).

    Article  Google Scholar 

  4. Salo, J. et al. Preprint at https://doi.org/10.1101/2021.05.27.21257896 (2021).

  5. Lopez Bernal, J. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2108891 (2021).

    Article  PubMed  Google Scholar 

  6. Li, B. et al. Preprint at https://doi.org/10.1101/2021.07.07.21260122 (2021).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links